ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Kidney/liver transplantation"

  • 2019 American Transplant Congress

    Alterations in Cerebral Blood Flow before and after Kidney Transplantation

    A. Gupta1, I. Choi2, R. Lepping3, P. Adany4, A. Jurgensen1, J. Klein1, D. Cibrik1, J. Burns5, W. Brooks2, P. Lee2

    1Division of Nephrology, The Kidney Institute, University of Kansas Medical Center, Kansas City, KS, 2Hoglund Brain Imaging Center, Department of Molecular & Integrative Physiology, University of Kansas Medical Center, Kansas City, KS, 3Hoglund Brain Imaging Center, Alzheimer’s Disease Center,, University of Kansas Medical Center, Kansas City, KS, 4Hoglund Brain Imaging Center, University of Kansas Medical Center, Kansas City, KS, 5Alzheimer’s Disease Center, Department of Neurology, University of Kansas Medical Center, Kansas City, KS

    *Purpose: End stage renal disease (ESRD) is associated with alterations in cerebral blood flow (CBF) likely secondary to disrupted cerebral autoregulation. In this study we…
  • 2019 American Transplant Congress

    Donation after Cardiac Simultaneous Liver-Kidney: An Updated Perspective

    R. Nunez, P. Morgan, A. Mathur, K. S. Reddy, A. Moss, B. Aqel, C. Jadlowiec

    Mayo Clinic AZ, Phoenix, AZ

    *Purpose: Historically, the outcomes from donation after cardiac death (DCD) donors have been shown to be inferior as compared to those of donation after brain…
  • 2019 American Transplant Congress

    Is Bariatric Surgery Feasible in the Setting of Liver and Kidney Transplants?

    L. M. Potter, A. Saharia, C. Mobley, K. Lunsford, M. Hobeika, N. Tariq, H. Podder, A. O. Gaber, R. M. Ghobrial

    Liver Transplant and Hepatobiliary Surgery, The Houston Methodist Hospital, Houston, TX

    *Purpose: Bariatric surgery benefits obese patients by promoting weight loss, improving quality of life, and reducing morbidity and mortality rates. There is concern, however, that…
  • 2019 American Transplant Congress

    The Comparison of Glycemic Profiles during Post-Operative Early Period between Liver and Kidney Transplantation Assessed by Continuous Glucose Monitoring System

    H. Yu1, H. Jin2, S. Lee2, J. Yang1, S. Park2, S. Ahn1, H. Hwang1

    1Surgery, Chonbuk National University Medical School and Hospital, Jeonju, Korea, Republic of, 2Internal Medicine, Chonbuk National University Medical School and Hospital, Jeonju, Korea, Republic of

    *Purpose: Newly developed hyperglycemia and worsening of previously well controlled glucose control are common after transplantation because of stressful condition and immunosuppressive agents including of…
  • 2019 American Transplant Congress

    Single Nucleotide Polymorphisms in NFACT1 rs2290154 Associated with the Risk of T Cell-Mediated Rejection of Recipients Following Kidney Transplantation

    Z. Wang, S. Fei, H. Chen, L. Sun, Z. Han, J. Tao, X. Ju, R. Tan, M. Gu

    No.300 Guangzhou Road of Nanjing, Nanjing, China

    *Purpose: Our study was to investigate the potential associations between the single nucleotide polymorphisms (SNPs) in NFATC1 and the risk of T cell-mediated rejection (TCMR)…
  • 2019 American Transplant Congress

    Use of a CMV Specific T Cell Immunity Assay in Late-Onset CMV Infection

    O. Beaird1, M. Carlson1, P. Gaynor1, D. Nanayakkara1, B. Abdalla2, S. Bunnapradist2, J. Schaenman1

    1Department of Internal Medicine - Division Infectious Diseases, UCLA, Los Angeles, CA, 2Department of Internal Medicine - Division Nephrology, UCLA, Los Angeles, CA

    *Purpose: To describe our clinical experience using a CMV Specific Cell Mediated Immunity (CMI) assay in solid organ transplant (SOT) recipients with late-onset CMV, defined…
  • 2019 American Transplant Congress

    Consistent High Burden of Arteriosclerosis in Pediatric Kidney Transplant Recipients

    K. Ostendorf1, N. Memaran1, B. Borchert-Mörlins1, J. von der Born1, E. Bauer1, A. von Wick1, J. Oh2, M. J. Kemper3, R. Büscher4, B. M. Schmidt5, A. Melk1

    1Department of Pediatric Kidney, Liver and Metabolic Diseases, Hannover Medical School, Hannover, Germany, 2Pediatric Nephrology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany, 3Department of Pediatrics, Asklepios Klinik Nord - Heidberg, Hamburg, Germany, 4Pediatric Nephrology, University Hospital, Essen, Germany, 5Department of Nephrology and Hypertension, Hannover Medical School, Hannover, Germany

    *Purpose: The second most common cause of death in pediatric kidney transplant (KT) recipients are cardiovascular (CV) diseases. We have previously shown that pulse wave…
  • 2019 American Transplant Congress

    Rapid Growth of HCV-Infected Donors for HCV-Uninfected Kidney and Liver Transplant Recipients in the United States

    M. Bowring, A. Shaffer, A. Massie, N. Desai, M. Sulkowski, A. Cameron, J. Garonzik-Wang, D. Segev

    Johns Hopkins University, Baltimore, MD

    *Purpose: Several single-center reports of using HCV-viremic organs for HCV-uninfected recipients were recently published in the US. In light of recent DAA introduction, we sought…
  • 2019 American Transplant Congress

    Letermovir for CMV Treatment in Solid Organ Transplant

    O. Witkowsky, M. Chunduru, A. Chung, A. Diez

    The Ohio State University Wexner Medical Center, Columbus, OH

    *Purpose: Letermovir (LET), a novel anti-CMV agent, was recently approved for CMV prophylaxis in stem cell transplant recipients and is currently under investigation as a…
  • 2019 American Transplant Congress

    Low Specific Gravity Of First Morning Urine Predicts Bkvn in Kidney Transplant Recipients With Bk Viruria

    G. Huang1, X. Chen1, Z. Wang2, Y. Nuertai2, W. Chen3, S. Yang3, P. Chen4, C. Wang1

    1Organ Transplant Center, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China, 2Department of Clinical Medicine, Sun Yat-sen University Zhongshan School of Medicine, Guangzhou, China, 3Department of Pathology, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China, 4Department of Clinical Laboratory, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China

    *Purpose: BK Polyomavirus nephropathy (BKVN) is an important cause of dysfunction and failure of renal transplants. BKV usually infects urinary tract retrogradely. The collecting duct…
  • « Previous Page
  • 1
  • …
  • 13
  • 14
  • 15
  • 16
  • 17
  • …
  • 24
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2026 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences